ClearanceBrief
Recall Z-0055-2025 · LLZ System, Image Processing, Radiological

Agfa Healthcare NV

Enterprise Imaging XERO Viewer- software application used for reference and diagnostic viewing of multispecialty medical imaging and non-imaging data . Enterprise Imaging XERO Viewer 8.0.0, 8.0.1, 8.1, 8.1.1, 8.1.2, 8.1.3,8.1.4, 8.2.0.000, 8.2.1.000, 8.2.2.000, 8.3.0.000, 8.3.1.000, 8.3.2.000, 8.4.0.000, 8.4.1.000 (including all SU s and HF s)

DateOct 10, 2024 (initiated Sep 6, 2024)
StatusOpen, Classified
ReasonSoftware defect, when an image has non-square pixel spacing, the reference/localizer line is incorrectly placed on the scout image in the XERO Viewet, may display the incorrect crosshair/line position on the non-coplanar/scout image with respect to the axial slice location. Inaccurate placement of reference lines or crosshairs have potential risk of misdiagnosis or mistreatment due to unintended shifts in the display of anatomical locations.
Root causeSoftware design
ActionAGFA issued Urgent: Mandatory Correction Important Information on 9/10/24. Letter states reason for recall, health risk and action to take: AGFA HealthCare will provide the software corrections for the affected versions. A patch is available for each of the following XERO Viewer version streams: - 8.4.x - 8.3.x - 8.2.x - 8.1.4.x - 8.1.2.x For versions of XERO Viewer prior to 8.1.2, the issue can be prevented from happening at your site by: - Using the XERO Viewer Extended Tools component (Xtend), if enabled. - Using the Enterprise Imaging Desktops viewer. - There is an option to disable the f
Quantity801 units
DistributionUS Nationwide distribution. Foreign: Argentina, Australia, Belgium, Chile, Canada, Colombia, Croatia, Cura¿ao, Cyprus, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Georgia, Greece, Hong Kong, Iceland, Ireland, Italy, Jordan, Kazakhstan, Kenya, Kuwait, Lebanon, Luxembourg, Me
FDA recordOpen on fda.gov

510(k) clearances named in this recall

K170434Enterprise Imaging XERO Viewer 8.1
Agfa Healthcare N.V., Jul 3, 2017